June 2017
M T W T F S S
« May    
 1234
567891011
12131415161718
19202122232425
2627282930  

Archives

Please support our Sponsors

Quantifying the Impact of NSAID-associated
Adverse Events

Quantifying the Impact of NSAID-associated
Adverse Events

The Chiro.Org Blog


SOURCE:   Am J Manag Care. 2013 (Nov); 19 (14 Suppl): s267–272

Michael Fine, MD

Health Net
736 Kendall Dr
Laguna Beach, CA 92651


Nonsteroidal anti-inflammatory drugs (NSAIDs) are widely used among patients experiencing many different types of pain, including inflammatory, acute pain (eg, injury, low back pain, headache, postoperative pain), and chronic pain (eg, rheumatoid arthritis, osteoarthritis).

However, both traditional NSAIDs and second-generation NSAIDs (cyclooxygenase-2 inhibitors) can lead to very expensive and serious adverse events. Gastrointestinal, cardiovascular, and renal complications associated with NSAIDs have been shown to be dose-dependent. In 2005, to help minimize these risks, the US Food and Drug Administration issued a public health advisory stating that “NSAIDs should be administered at the lowest effective dose for the shortest duration consistent with individual patient treatment goals.”

This article reviews the undue clinical and economic burden associated with NSAID-related serious adverse events.


From the FULL TEXT Article:

Introduction

Nonsteroidal anti-inflammatory drugs (NSAIDs) are the cornerstone of pain management in patients who have inflammatory, acute pain (eg, headache, postoperative pain, and orthopedic fractures), and chronic pain (eg, rheumatoid arthritis, osteoarthritis, and gout). [1, 2] Approximately 70% of people 65 years or older use NSAIDs at least once per week, with half of them taking at least 7 doses per week. In 2000, more than 111 million prescriptions were written for NSAIDs in the United States, at an approximate cost of $4.8 billion. [3] The use of NSAIDs is likely to increase even more as the US population continues to age and experience painful conditions that are more common among older adults. [4]

There are more articles like this @ our:

Iatrogenic Injury Page

Both traditional NSAIDs and the second generation cyclooxygenase-2 (COX–2) inhibitors offer superior efficacy compared with acetaminophen, but also carry significant risk for serious gastrointestinal (GI), cardiovascular (CV), and renal adverse events. [1, 5–7] A systematic review of 17 prospective observational studies found that 11% of preventable drug-related hospital admissions could be attributed to NSAIDs. [8] Studies have documented that the risk of adverse events associated with NSAIDs are both dose-dependent and duration dependent. [1, 7, 9]


Read the rest of this Full Text article now!


Leave a Reply